Page 5 - Bharat Biotech

Ocugen to commercialise Covaxin in Mexico, working on US market too

Covaxin has EUA in Mexico for use in adults; data submitted for EUA for children aged 2-18 years

Fallout of WHO observations: Covaxin's Phase 2/3 trials in US put on hold

WHO had earlier suspended the supply of Covaxin through US procurement agencies, after its inspectors identified GMP (good manufacturing practice) deficiencies in the Bharat Biotech's plants

SII to give free Covishield vials to pvt vaccination centres: Here's why

Vaccine majors SII and Bharat Biotech said they have decided to cut prices of precaution dose of their respective Covid-19 vaccines to Rs 225 per shot for private hospitals after discussion with govt

SII, Bharat Biotech cut Covid vaccine prices for pvt hospitals to Rs 225

SII and Bharat Biotech have been major suppliers of Covid-19 vaccines to the government so far

Japan recognises Covaxin to facilitate travel from April 10: Bharat Biotech

Various countries including Australia, have recognised Covaxin for facilitating travel

2 Covaxin shots provide high immunity in breakthrough cases: ICMR

A recent ICMR study has shown that breakthrough cases after full vaccination with Covaxin have shown a significant increase in the immune response against coronavirus' variants of concern

Don't slack off

Vaccination programme cannot lose govt attention

'No impact of WHO action on Covaxin, not supplied to any UN agency'

Bharat Biotech also said the WHO announcement will not impact the Ocugen trials

No issue with Covaxin certificate: Bharat Biotech on WHO suspending vaccine

Bharat biotech says there are no issues with Covaxin or its certification, further we will focus on pending facility maintenance, has no supply commitments pending for UN agency.

No impact on efficacy, safety of Covaxin: Bharat Biotech on WHO suspension

The vaccine manufacturer has said that the company is slowing down the production of Covaxin for facility optimization.

WHO suspends UN supply of Bharat Biotech's Covaxin vaccine for Covid-19

This is to allow the manufacturer to upgrade facilities and address deficiencies found in an inspection

Bharat Biotech slows down COVAXIN production for facility optimisation

Bharat Biotech on Friday announced the temporary slowing down of production of COVAXIN across its manufacturing facilities

Bharat Biotech slows down Covaxin production as it sees decrease in demand

'For the coming period, the company will focus on pending facility maintenance, process and facility optimization activities,' the Hyderabad-based company said

Science more challenging than entrepreneurship, says Krishna Ella

Bharat Biotech may have gained immense popularity with its COVID-19 vaccine Covaxin, but the firm's founder and chairman Krishna Ella says science remains his passion

Bharat Biotech enters into partnership with Biofabri for TB vaccine

This partnership will guarantee the supply of tuberculosis (TB) vaccines in more than 70 countries, especially in Southeast Asia and sub-Saharan Africa

Bharat Biotech sees no impact of Ukraine conflict on vaccine supply chains

Unlike several Western companies, no Indian company has publicly withdrawn from the region.

Global community can tap India's Covid vaccine capacity, say firms

Bharat Biotech MD Krishna Ella said India now has four BSL-4 containment facilities, equal to that of the UK.

Bharat Bio working on TB vaccine, to ink pact with a firm for technology

Without providing details on the name of the firm with which BBIL will be inking MoU, Ella said the TB vaccine is currently undergoing phase 3 clinical trials

Covaxin to be evaluated as Covid vaccine candidate in US: Bharat Biotech

Ocugen Inc is co-developing the Covaxin vaccine candidate for Covid in the US and Canada

Top headlines: L&T Q3 net falls; nod for Bharat Bio's intranasal dose trial

Business Standard brings you the top headlines on Friday